| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 07/18/2001 | CN1304316A Adenovirus vector containing heterologous peptide epitope in HI loop of fiber knob |
| 07/18/2001 | CN1303924A Method for culturing anchorage dependent animal cell to produce virus by using magnetic stable fluidized bed |
| 07/17/2001 | US6261823 Subjecting adenovirus preparation to anion-exchange chromatography, eluting virus, then to size exclusion chromatography, and eluting virus |
| 07/17/2001 | US6261807 Method for preparing a recombinant adenovirus genome |
| 07/17/2001 | US6261765 In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs) |
| 07/17/2001 | US6261762 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and the use of these DNA clones polypeptides in diagnostic kits |
| 07/17/2001 | US6261555 Reovirus for the treatment of neoplasia |
| 07/17/2001 | US6261552 Genomes with deletion or mutation |
| 07/17/2001 | US6261551 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof |
| 07/17/2001 | CA2110519C Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits detection of bovine herpesvirus type 1 |
| 07/17/2001 | CA2074502C Vaccines |
| 07/12/2001 | WO2001049829A1 Compositions and methods for efficient aav vector production |
| 07/12/2001 | WO2001049828A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049614A1 Process and means to prevent microorganisms blooming in an aquatic system |
| 07/12/2001 | WO2001002548A3 Methods for the propagation of lytic organisms |
| 07/12/2001 | WO2000074722A3 Modification of biological elements |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/11/2001 | EP1114189A1 Recombinant newcastle disease virus rna expression systems and vaccines |
| 07/11/2001 | EP0587832B1 Method for testing blood units for viral contamination |
| 07/11/2001 | CN1303442A Method |
| 07/11/2001 | CN1303433A Recombinant potyvirus construct and use thereof |
| 07/11/2001 | CN1303426A Novel methods for rescue of RNA viruses |
| 07/10/2001 | US6258598 EBV-infected stomach cancer cell line |
| 07/10/2001 | US6258595 Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| 07/10/2001 | CA1341272C Modified baculovirus, process for its preparation and its use as vector for the expression of genes |
| 07/05/2001 | WO2001048233A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 07/05/2001 | WO2001048155A2 Method using filtration aids for the separation of virus vectors from nucleic acids and other cellular contaminants |
| 07/05/2001 | WO2001047955A2 Improvements in or relating to immune responses to hiv |
| 07/05/2001 | WO2001002592A3 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 07/05/2001 | WO2000073478A3 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
| 07/05/2001 | WO2000061621A3 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/05/2001 | WO2000046355A8 Telomerase reverse transcriptase transcriptional regulatory sequences |
| 07/05/2001 | CA2395820A1 Method using filtration aids for the separation of virus vectors from nucleic acids and other cellular contaminants |
| 07/05/2001 | CA2395454A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 07/04/2001 | EP1112372A1 Alternatively targeted adenovirus |
| 07/04/2001 | EP1112371A1 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 07/04/2001 | EP1112361A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 07/04/2001 | EP1112350A2 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus |
| 07/04/2001 | CN1302334A Retroviral delivery system |
| 07/04/2001 | CN1302330A Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
| 07/03/2001 | US6255071 Mammalian viral vectors and their uses |
| 07/03/2001 | US6254873 Dengue virus protection |
| 07/03/2001 | US6254862 Replication-competent adenovirus vectors |
| 07/03/2001 | CA2116348C Sirs vaccine and diagnosis method |
| 06/28/2001 | WO2001046408A2 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 06/28/2001 | WO2001046390A2 Method of inactivating microorganisms |
| 06/28/2001 | WO2001045737A2 Herpes simplex virus-1 glycoprotein c mutants for treating unwanted hyperproliferative cell growth |
| 06/28/2001 | WO2001045669A1 Therapeutic use of particles displaying pathogen-specific binding moieties |
| 06/28/2001 | WO2000076450A3 Recombinant adenoviruses for the sodium/iodide symporter (nis) |
| 06/28/2001 | WO2000061613A3 Channel forming toxins as antiviral agents |
| 06/28/2001 | CA2395269A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 06/27/2001 | EP1111040A1 Infection of eukaryotic cells with viruses in vitro |
| 06/27/2001 | EP1109906A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 06/27/2001 | EP1109892A2 Methods for generating high titer helper-free preparations of released recombinant aav vectors |
| 06/27/2001 | EP0629131B1 Antigens protective against (echinococcus granulosus) infection and vaccines containing such antigens |
| 06/27/2001 | CN1301297A Medium and method for viral propagation and growth |
| 06/27/2001 | CN1067722C Adenoviral vectors |
| 06/27/2001 | CN1067721C Hepatitis B surface antigen containing front surface antigen 1 and 2. immunodeterminant |
| 06/26/2001 | US6251677 Genetically engineered microorganism; for use in gene therapy |
| 06/26/2001 | US6251654 Modified small RNA viruses |
| 06/26/2001 | US6251644 Method for inactivating non-enveloped viral contaminants with a photosensitizer by increasing viral permeability to the photosensitizer |
| 06/26/2001 | US6251640 Genetically engineered virus having tata element promoter, tet operator sequence, and a gene which inhibits replication of virus when expressed; gene therapy; vaccines; viricides |
| 06/26/2001 | US6251404 Collecting a sample of a naturally occurring isolated virus such as the iowa strain, and a naturally occuring strain that causes lesions in colostrum deprived piglets, treating to deactivate virus and admixing with carrier |
| 06/26/2001 | US6251403 Comprising a foreign dna encoding a cytokine inserted into a swinepox virus genome within a nonessential region and expressed in a host cell into which the virus is introduced; swinepox virus as a vector for delivery of vaccine antigens |
| 06/26/2001 | US6251397 Purified polypeptides encoded by open reading frames (orf's) of a highly virulent strain of the virus as determined by its ability to induce lung lesions in 51.9% of colostrum-deprived piglets; vaccines |
| 06/26/2001 | CA1341263C Recombinant fowlpox virus, heterologous protein expression vectors, and fowl vaccines derived from this virus |
| 06/21/2001 | WO2001044458A2 Bovine immunodeficiency virus (biv) based vectors |
| 06/21/2001 | WO2001011034A3 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| 06/21/2001 | WO2000020574A9 Fusions of scaffold proteins with random peptide libraries |
| 06/21/2001 | WO1998011243A9 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein |
| 06/20/2001 | EP1108787A2 Production of vaccines |
| 06/20/2001 | EP1108783A2 Oligonucleotide-mediated nucleic acid recombination |
| 06/20/2001 | EP1108781A2 Method for making character strings, polynucleotides and polypeptides |
| 06/20/2001 | EP1108743A2 Virus-binding particles, virus-separating reagent, separation of viruses, and detection of viruses |
| 06/20/2001 | EP1108069A1 Method for assessing the relative purity of viral gene transfer vector stocks |
| 06/20/2001 | EP1108051A2 Inducible expression system |
| 06/20/2001 | EP1108050A1 Methods and compositions for expressing heterologous genes in hepatocytes using hepadnaviral vectors |
| 06/20/2001 | EP1108049A2 Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences |
| 06/20/2001 | EP1108048A1 Cationic complexes of polymer-modified adenovirus |
| 06/20/2001 | EP1108047A1 Targeted adenovirus vectors for delivery of heterologous genes |
| 06/20/2001 | EP1108046A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 06/20/2001 | EP1108034A2 Attenuated salmonella spi2 mutants as antigen carriers |
| 06/20/2001 | CN1300325A Amphotropic retrovirus packaging cell line, process for its production and use thereof |
| 06/20/2001 | CN1299868A Construction and use of recombinant herpes simplex virus |
| 06/19/2001 | US6248872 Nucleotide sequences which code enzymatic protein; for use in detection and treatment of dirofilaria infection |
| 06/19/2001 | US6248721 Method of using mouse model for evaluation of HIV vaccines |
| 06/19/2001 | US6248715 Administering non-fucosylated polypeptide for treatment of metastasis, inflammation, rheumatoid arthritis, eye diseases |
| 06/19/2001 | US6248588 Medium for preserving biological materials |
| 06/19/2001 | US6248582 Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV |
| 06/19/2001 | US6248578 Infectious clone for human parainfluenza virus type 3 |
| 06/19/2001 | US6248328 HIV-1 virus isolates of a subtype and its differential diagnostics, a vaccine against HIV-1 virus infections of this subtype and method of producing same, use of the HIV-1 virus isolates |
| 06/19/2001 | US6248320 Herpes simplex virus; genetic engineering |
| 06/19/2001 | CA1341258C Defective recombinant retrovirus and its use for insertion of predetermined protein coding sequences in the genome of cell cultures |
| 06/14/2001 | WO2001042780A1 IN VITRO METHOD FOR DISASSEMBLY/REASSEMBLY OF PAPILLOMAVIRUS VIRUS-LIKE PARTICLES (VLPs) |
| 06/14/2001 | WO2001042460A1 Polynucleotides, polypeptides, remedies for cancer and vaccines |
| 06/14/2001 | WO2001042459A1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 06/14/2001 | WO2001042445A2 USE OF RECOMBINANT PARAINFLUENZA VIRUSES (PIVs) AS VECTORS TO PROTECT AGAINST INFECTION AND DISEASE CAUSED BY PIV AND OTHER HUMAN PATHOGENS |
| 06/14/2001 | WO2001042429A1 Infection of eukaryotic cells with viruses in vitro |
| 06/14/2001 | WO2001042307A1 MUTANT ERα AND TEST SYSTEMS FOR TRANSACTIVATION |